Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-052392
Filing Date
2020-04-28
Accepted
2020-04-28 16:09:40
Documents
5
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-2046_3defa14a.htm DEFA14A 32788
2 GRAPHIC g20463bci001.jpg GRAPHIC 100705
3 GRAPHIC g20463bci002.jpg GRAPHIC 158543
4 GRAPHIC g20463bci003.jpg GRAPHIC 72053
5 GRAPHIC g20463bci004.jpg GRAPHIC 24234
  Complete submission text file 0001104659-20-052392.txt   523825
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 20825078
SIC: 2834 Pharmaceutical Preparations